Robert Charles Breedlove insider trades
Open-market stock purchases and sales by Robert Charles Breedlove, Principal Accounting Officer at Phathom Pharmaceuticals, Inc, from SEC Form 4 filings since May 19, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 3, 2026 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $4.2K |
| Jul 14, 2026 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $17.2K |
| Feb 27, 2026 | PHAT Phathom Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 27, 2026 | PHAT Phathom Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 27, 2026 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $12.1K |
| Feb 27, 2026 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $5.2K |
| Jan 21, 2026 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $10.6K |
| Dec 18, 2025 | PHAT Phathom Pharmaceuticals, Inc | Sold (not open market) | $3.7K |
| Nov 3, 2025 | PHAT Phathom Pharmaceuticals, Inc | Sold | $7.1K |
Companies traded
- PHAT Phathom Pharmaceuticals, Inc: 3 sales, last Sep 3, 2026
Get free alerts when Robert Charles Breedlove files a new trade →